Corcept Therapeutics Statistics
NASDAQ: CORTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
119.60+0.03 (+0.03%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Corcept Therapeutics by the numbers
Corcept Therapeutics has a market capitalization of $12.93 billion based on 108.10M shares outstanding. Its trailing P/E ratio is 265.8, above the 4-company peer median of 81.0, and its forward P/E is 27.2. The stock trades 4.8% above its 50-day average and 70.1% above its 200-day average.
Average daily trading volume is 1.31M shares, or about $156.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CORT valuation vs. peer median
| Metric | CORT | Peer median | Difference |
|---|---|---|---|
| Market cap | $12.93B | $11.22B | +15% |
| P/E (TTM) | 265.8 | 81.0 | +228% |
| Forward P/E | 27.2 | 19.0 | +43% |
| Avg. volume | 1.31M | 2.38M | -45% |
Peer median across 8 companies: BBIO, SMMT, MDGL, ELAN, ASND, BMRN, RDY, PTGX.
Valuation
- Market cap
- $12.93B
- P/E (TTM)
- 265.78
- Forward P/E
- 27.17
- Price / sales (latest FY)
- 16.98
- EPS (TTM)
- $0.45
- Shares outstanding
- 108.10M
Price and trading
- Previous close
- 119.57
- Open
- 118.60
- Day range
- 117.23 – 122.00
- 52-week range
- 28.66 – 126.38
- 52-week change
- +32.42%
- 50-day moving average
- 114.10
- Beta
- —
- Volume
- 628.05K
- Average volume
- 1.31M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 12.93B
- Pe
- 265.78
- Forward Pe
- 27.17
- Eps
- 0.45
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 126.38
- Week52 Low
- 28.66
- Avg Volume
- 1.31M
- Shares Outstanding
- 108.10M
- Ma50
- 114.10
- Ma200
- 70.31
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -5.36%
- Pct From52w Low
- 317.31%